论文部分内容阅读
蒙特利尔消息:魁北克城一家生物技术公司已研制出一种具有高度敏感性的检验方法,以提高最常见形式的膀胱癌检测。一项有300名病人(102名无症状的对照者和198名确诊为膀胱癌的病人)的多中心研究,应用ImmunoCyt(一
Montreal News: A biotechnology company in Quebec City has developed a highly sensitive test to increase the most common forms of bladder cancer testing. A multicenter study of 300 patients (102 asymptomatic controls and 198 patients diagnosed with bladder cancer) received ImmunoCyt